Adjuvant Chemoendocrine Therapy
Adjuvant chemoendocrine therapy is a combination of chemotherapy and hormonal treatments that may be administered to patients after surgery for a nonmetastatic tumor with the goal of decreasing the risk of cancer recurrence.
Adjuvant chemoendocrine therapy is potentially useful for tumors which are responsive to both cytotoxic chemotherapy and hormonal interventions. The growth of these types of tumors is boosted by hormones and usually it may be limited not only by blocking these hormones but also by chemotherapy. Adjuvant chemoendocrine therapy is a standard treatment for early breast cancer, while it is experimental in prostate cancer, and it is not generally an option in other tumors with possible endocrine responsiveness such as endometrial cancer or ovarian cancer.
Surgery generally remains the first step for...
KeywordsBreast Cancer Prostate Cancer Adjuvant Hormone Therapy Progesterone Receptor Expression Endocrine Responsiveness
- Castiglione-Gertsch M, O’Neill A, Price KN et al (2003) International Breast Cancer Study Group adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95(24):1833–1846CrossRefPubMedGoogle Scholar
- Stearns V, Davidson NE (2004) Adjuvant chemotherapy and chemoendocrine therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Disease of the breast, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 893–919Google Scholar